SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that researchers from Boston University and Howard University will perform the first genome-wide scan of an African American cohort searching for genes associated with obesity, hypertension, diabetes and metabolic syndrome using the Affymetrix GeneChip® Human Mapping 500K Array Set.
